ArticleDrugs in context2025

Tezepelumab for early-onset severe allergic asthma with persistent airflow limitation and small airway dysfunction: a treatable traits approach.

Francesco Menzella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.